Supportive Care in Cancer

, Volume 24, Issue 10, pp 4413–4422 | Cite as

Prevalence and associates of psychological distress in haematological cancer survivors

  • Alix E. Hall
  • Rob W. Sanson-Fisher
  • Mariko L. Carey
  • Chris Paul
  • Anna Williamson
  • Ken Bradstock
  • H. Sharon Campbell
Original Article

Abstract

Purpose

To explore outcomes of psychological distress, including anxiety, depression and stress, amongst adult haematological cancer survivors, with a specific focus on potential differences between rural and urban survivors.

Methods

One thousand four hundred fourteen urban and rural survivors were recruited from five Australian population-based cancer registries and completed a self-report pen-and-paper survey on their well-being, including the Depression Anxiety and Stress Scale 21-item version.

Results

A quarter of survivors were identified as reporting above normal levels of anxiety and depression, respectively, and almost one fifth (17 %) reported above normal levels of stress. There were no statistically significant differences in the percentage of rural and urban survivors reporting above normal levels of anxiety, depression, or stress. Survivors who had experienced financial burden due to their cancer or were of middle age had higher odds of reporting multiple domains of psychological distress, compared to their counterparts.

Conclusions

Haematological cancer survivors diagnosed during middle age or who experience increased financial burden as a result of their diagnosis may require additional support and care with regards to psychological distress.

Keywords

Cancer Oncology Distress Haematological cancer Geographical location 

References

  1. 1.
    Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J, Lamont L, Bultz BD (2004) High levels of untreated distress and fatigue in cancer patients. Br J Cancer 90(12):2297–2304PubMedPubMedCentralGoogle Scholar
  2. 2.
    Linden W, Vodermaier A, MacKenzie R, Greig D (2012) Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 141(2):343–351CrossRefPubMedGoogle Scholar
  3. 3.
    Allart P, Soubeyran P, Cousson-Gélie F (2013) Are psychosocial factors associated with quality of life in patients with haematological cancer? A critical review of the literature. Psycho-Oncology 22(2):241–249PubMedGoogle Scholar
  4. 4.
    Ell K, Sanchez K, Vourlekis B, Lee PJ, Dwight-Johnson M, Lagomasino I, Russell C (2005) Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol 23(13):3052–3060CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160(14):2101–2107CrossRefPubMedGoogle Scholar
  6. 6.
    Molassiotis A, Wilson B, Blair S, Howe T, Cavet J (2011) Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psycho-Oncology 20(1):88–97CrossRefPubMedGoogle Scholar
  7. 7.
    Montgomery C, Pocock M, Titley K, Lloyd K (2003) Predicting psychological distress in patients with leukaemia and lymphoma. J Psychosom Res 54(4):289–292CrossRefPubMedGoogle Scholar
  8. 8.
    Sherman AC, Simonton S, Latif U, Plante TG, Anaissie EJ (2009) Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation. Biol Blood Marrow Transplant 15:12–20CrossRefPubMedGoogle Scholar
  9. 9.
    Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, Kaasa S (2004) A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation. Bone Marrow Transplant 34:257–266CrossRefPubMedGoogle Scholar
  10. 10.
    Tecchio C, Bonetto C, Bertani M, Cristofalo D, Lasalvia A, Nichele I, Bonani A, Andreini A, Benedetti F, Ruggeri M, Pizzolo G (2013) Predictors of anxiety and depression in hematopoietic stem cell transplant patients during protective isolation. Psycho-Oncology 22:1790–1797CrossRefPubMedGoogle Scholar
  11. 11.
    Clinton-McHarg T, Carey M, Sanson-Fisher R, Tzelepis F, Bryant J, Williamson A (2014) Anxiety and depression among haematological cancer patients attending treatment centres: prevalence and predictors. J Affect Disord 165:176–181CrossRefPubMedGoogle Scholar
  12. 12.
    Priscilla D, Hamidin A, Azhar MZ, Noorjan KON, Salmiah MS, Bahariah K (2011) Assessment of depression and anxiety in haematological cancer patients and their relationship with quality of life. East Asian Arch Psychiatr 21:108–114Google Scholar
  13. 13.
    Santos FR, Kozasa EH, Maria de Lourdes LF, Colleoni GW, Leite JR (2006) Psychosocial adaptation and quality of life among Brazilian patients with different hematological malignancies. J Psychosom Res 60(5):505–511CrossRefPubMedGoogle Scholar
  14. 14.
    McCorkle R, Cooke E (2013) Psychosocial aspects of hematologic disorders. In: Hoffman R, Benz EJ, Silberstein LE, Heslop HE, Weitz JI, Anastais J (eds) Hematology: basic principles and practice, 6th edn. Elsevier Inc., PhiladelphiaGoogle Scholar
  15. 15.
    National Institute for Clinical Excellence (2003) Guidance on cancer services- improving outcomes in haematological cancers: the manual. NICE, London, UKGoogle Scholar
  16. 16.
    Butow PN, Phillips F, Schweder J, White K, Underhill C, Goldstein D (2012) Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review. Support Care Cancer 20(1):1–22CrossRefPubMedGoogle Scholar
  17. 17.
    Weaver KE, Geiger AM, Lu L, Case LD (2013) Rural-urban disparities in health status among US cancer survivors. Cancer 119(5):1050–1057CrossRefPubMedGoogle Scholar
  18. 18.
    Boyes AW, Girgis A, D’Este C, Zucca AC (2011) Flourishing or floundering? Prevalence and correlates of anxiety and depression among a population-based sample of adult cancer survivors 6 months after diagnosis. J Affect Disord 135(1):184–192CrossRefPubMedGoogle Scholar
  19. 19.
    Schootman M, Homan S, Weaver KE, Jeffe DB, Yun SY (2013) The health and welfare of rural and urban cancer survivors in Missouri. Prev Chronic Dis 10:130052CrossRefGoogle Scholar
  20. 20.
    Paul CL, Hall AE, Carey ML, Cameron EC, Clinton‐McHarg T (2013) Access to care and impacts of cancer on daily life: do they differ for metropolitan versus regional hematological cancer survivors? J Rural Health 29(s1):s43–50CrossRefPubMedGoogle Scholar
  21. 21.
    Dauch S, Dolbeault S, Reich M (2013) Depression in cancer patients. Eur J Cancer Suppl 2:205–215CrossRefGoogle Scholar
  22. 22.
    Traeger L, Greer JA, Fernandez-Robles C, Temel JS, Pirl WF (2012) Evidence-based treatment of anxiety in patients with cancer. J Clin Oncol 30(11):1197–1205CrossRefPubMedGoogle Scholar
  23. 23.
    Feuerstein M (2007) Defining cancer survivorship. J Cancer Surviv 1:5–7CrossRefPubMedGoogle Scholar
  24. 24.
    Twombly R (2004) What’s in a name: who is a cancer survivor? J Nat Cancer Inst 96(19):1414–1415CrossRefPubMedGoogle Scholar
  25. 25.
    Australian Bureau of Statistics (2013) Australian Statistical Geography Standard (ASGS): volume 5—remoteness structure. ABS Catalogue No. 1270.0.55.005. ABS, CanberraGoogle Scholar
  26. 26.
    Hall AE, Sanson-Fisher RW, Lynagh MC, Threlfall T, D’Este CA (2013) Format and readability of an enhanced invitation letter did not affect participation rates in a cancer registry-based study: a randomized controlled trial. J Clin Epidemiol 66(1):85–94CrossRefPubMedGoogle Scholar
  27. 27.
    Hall A, D’Este C, Tzelepis F, Sanson-Fisher R, Lynagh M (2014) The Survivor Unmet Needs Survey (SUNS) for haematological cancer survivors: a cross-sectional study assessing the relevance and psychometric properties. BMC Health Serv Res 14(1):211–223CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Lynagh M, Clinton-McHarg T, Hall A, Sanson-Fisher R, Stevenson W, Tiley C, Bisquera A (2015) Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies. Exp Hematol Oncol 4(15)Google Scholar
  29. 29.
    Lovibond SH, Lovibond PF (1995) Manual for the Depression Anxiety Stress Scales, 2nd edn. Psychology Foundation Monograph, SydneyGoogle Scholar
  30. 30.
    Brown TA, Chorpita BF, Korotitsch W, Barlow DH (1997) Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behav Res Ther 35(1):79–89CrossRefPubMedGoogle Scholar
  31. 31.
    Gloster AT, Rhoades HM, Novy D, Klotsche J, Senior A, Kunik M, Stanley MA (2008) Psychometric properties of the Depression Anxiety and Stress Scale-21 in older primary care patients. J Affect Disord 110(3):248–259CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    School of Psychology University of New South Wales (2011) DASS FAQ (frequently asked questions). http://www2.psy.unsw.edu.au/Groups/Dass/DASSFAQ.htm. Accessed March 2013
  33. 33.
    National Comprehensive Cancer Network (2013) NCCN clinical practice guidelines in oncology: distress management version 2.2103. NCCN,Google Scholar
  34. 34.
    Walker J, Sawhney A, Hansen CH, Ahmed S, Martin S, Symeonides S, Murray G, Sharpe M (2014) Treatment of depression in adults with cancer: a systematic review of randomized controlled trials. Psychol Med 44:897–907CrossRefPubMedGoogle Scholar
  35. 35.
    Goldstein D, Underhill C (2007) Regional cancer services in Australia: some evidence of improvement but a long way to go. Cancer Forum 2(31)Google Scholar
  36. 36.
    McGrath P (2000) It’s horrendous-but really, what can you do? Preliminary findings on financial impact of relocation for specialist treatment. Aust Health Rev 23(3):94–103CrossRefPubMedGoogle Scholar
  37. 37.
    McGrath P, Seguerra J (2000) The patient transit assistance scheme: a consumer’s perspective. Aust J Rural Health 8(4):232–238CrossRefPubMedGoogle Scholar
  38. 38.
    Bleyer A (2005) The adolescent and young adult gap in cancer care and outcome. Curr Probl Pediatr Adolesc Health Care 35(5):182–217CrossRefPubMedGoogle Scholar
  39. 39.
    McAdams DP, Olson BD (2010) Personality developing continuity and change over the life course. Annu Rev Psychol 61:517–542CrossRefPubMedGoogle Scholar
  40. 40.
    Hammond CT, Beckjord EB, Arora NK, Bellizzi KM, Jeffery DD, Aziz NM (2008) Non-Hodgkin’s lymphoma survivors’ fertility and sexual function-related information needs. Fertil Steril 90(4):1256–1258CrossRefPubMedGoogle Scholar
  41. 41.
    Smith T, Stein KD, Mehta CC, Kaw C, Kepner JL, Buskirk T, Baker F (2007) The rationale, design, and implementation of the American Cancer Society’s studies of cancer survivors. Cancer 109(1):1–12CrossRefPubMedGoogle Scholar
  42. 42.
    Watson N, Wooden M (2009) Identifying factors affecting longitudinal survey response. In: Lynn P (ed) Methodology of longitudinal surveys. John Wiley & Sons Ltd, ChichesterGoogle Scholar
  43. 43.
    Australian Bureau of Statistics (2015) 3218.0 regional population growth, Australia population estimates by remoteness area, 2004 to 2014. ABS, CanberraGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Alix E. Hall
    • 1
    • 2
  • Rob W. Sanson-Fisher
    • 1
    • 2
  • Mariko L. Carey
    • 1
    • 2
  • Chris Paul
    • 1
    • 2
  • Anna Williamson
    • 3
  • Ken Bradstock
    • 4
    • 5
  • H. Sharon Campbell
    • 6
  1. 1.Priority Research Centre for Health Behaviour, Faculty of HealthThe University of NewcastleCallaghanAustralia
  2. 2.Hunter Medical Research InstituteNew Lambton HeightsAustralia
  3. 3.The Leukaemia FoundationWindsorAustralia
  4. 4.Haematology DepartmentWestmead HospitalWestmeadAustralia
  5. 5.Sydney Medical SchoolUniversity of SydneySydneyAustralia
  6. 6.Propel Centre for Population Health ImpactUniversity of WaterlooWaterlooCanada

Personalised recommendations